MedTrace Logo

German Centre for Infection Research HIV Translational Platform

NCT02149004 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2017-10-27

No results posted yet for this study

Summary

Despite major advances in therapy and management, HIV/AIDS continues to be a major cause of infectious disease morbidity and mortality on a global scale. The discovery of effective antiretroviral treatment has turned HIV infection into a manageable chronic disease in most patients with access to care. However, the different economic and epidemiologic situation in developing and developed countries requires different research priorities, so that three main challanges are universal and in focus of research of the DZIF HIV Translational Platform:

* Prevention of HIV infection
* Long-term life with HIV
* HIV cure

The "Translation Reserach HIV" will bring together clinical researchers in HIV infection in order to develop new treatment options to the above mentioned main challanges. It will take advantage of existing expertise (e.g. basic science, novel targets for treatment and HIV eradiation) of the partner sites. This platform is necessary because Germany's HIV research has suffered in the past from a lack of integration between its excellent basic science and clinical research. In addition, there was too little integration into networks that address the main international challenges. There is an urgent need to link these research strands through dedicated structures emphasising the translation of preclinical results into new therapies.

Conditions

Sponsors & Collaborators

  • German Center for Infection Research

    collaborator OTHER

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University Hospital of Cologne

    lead OTHER

Principal Investigators

  • Jörg Janne Vehreschild, MD · University Hospital of Cologne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2035-01-31
Completion
2035-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149004 on ClinicalTrials.gov